Genomics: Understanding DNA, RNA, Transcription, and Translation

Deoxyribonucleic acid (DNA) is a molecule composed of two chains that coil around each other to form a double helix. DNA is organised into chromosomes, and each chromosome is made up of DNA coiled around proteins called histones. RNA, on the other hand, is made from a long chain of nucleotide units and is usually single-stranded. RNA is transcribed from DNA by enzymes called RNA polymerases and is central to protein synthesis.

Transcription is the synthesis of RNA from a DNA template, and it consists of three main steps: initiation, elongation, and termination. RNA polymerase binds at a sequence of DNA called the promoter, and the transcriptome is the collection of RNA molecules that results from transcription. Translation, on the other hand, refers to the synthesis of polypeptides (proteins) from mRNA. Translation takes place on ribosomes in the cell cytoplasm, where mRNA is read and translated into the string of amino acid chains that make up the synthesized protein.

The process of translation involves messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). Transfer RNAs, of tRNAs, connect mRNA codons to the amino acids they encode, while ribosomes are the structures where polypeptides (proteins) are built. Like transcription, translation also consists of three stages: initiation, elongation, and termination. In initiation, the ribosome assembles around the mRNA to be read and the first tRNA carrying the amino acid methionine. In elongation, the amino acid chain gets longer, and in termination, the finished polypeptide chain is released.

HPA Axis Dysfunction in Mood Disorders

The HPA axis, which includes regulatory neural inputs and a feedback loop involving the hypothalamus, pituitary, and adrenal glands, plays a central role in the stress response. Excessive secretion of cortisol, a glucocorticoid hormone, can lead to disruptions in cellular functioning and widespread physiologic dysfunction. Dysregulation of the HPA axis is implicated in mood disorders such as depression and bipolar affective disorder.

In depressed patients, cortisol levels often do not decrease as expected in response to the administration of dexamethasone, a synthetic corticosteroid. This abnormality in the dexamethasone suppression test is thought to be linked to genetic of acquired defects of glucocorticoid receptors. Tricyclic antidepressants have been shown to increase expression of glucocorticoid receptors, whereas this is not the case for SSRIs.

Early adverse experiences can produce long standing changes in HPA axis regulation, indicating a possible neurobiological mechanism whereby childhood trauma could be translated into increased vulnerability to mood disorder. In major depression, there is hypersecretion of cortisol, corticotropin-releasing factor (CRF), and ACTH, and associated adrenocortical enlargement. HPA abnormalities have also been found in other psychiatric disorders including Alzheimer’s and PTSD.

In bipolar disorder, dysregulation of ACTH and cortisol response after CRH stimulation have been reported. Abnormal DST results are found more often during depressive episodes in the course of bipolar disorder than in unipolar disorder. Reduced pituitary volume secondary to LHPA stimulation, resulting in pituitary hypoactivity, has been observed in bipolar patients.

Overall, HPA axis dysfunction is implicated in mood disorders, and understanding the underlying mechanisms may lead to new opportunities for treatments.

Deep brain stimulation (DBS) for treatment resistant depression targets specific brain regions based on their known involvement in pleasure, reward, and mood regulation. The nucleus accumbens is targeted due to its role in pleasure and reward processing. The inferior thalamic peduncle is targeted based on PET studies showing hyperactivity in depression. The lateral habenula is chosen due to observed hypermetabolism in depressed patients. The subgenual cingulate gyrus is targeted due to its hyperactivity in depression. The ventral capsule/ventral striatum is chosen based on its association with improved mood and reduced depressive symptoms following ablation treatments for OCD and depression.

Lurasidone may cause akathisia and sedation as common side effects, which can vary based on the dosage. Its metabolic profile is neutral. However, doses lower than 37 mg are unlikely to produce desired results.

Linkage and LOD Scores in Genetics

In genetics, when genes are located close to each other on a chromosome, they tend to be inherited together and are referred to as linked genes. Conversely, genes that are far apart of located on different chromosomes are inherited independently and are said to follow independent assortment. To determine the relative distance between two genes, scientists can analyze the offspring of an organism that displays two strongly linked traits and calculate the percentage of offspring where the traits do not co-segregate.

To determine if there is evidence for linkage between two genes, scientists use a statistical method called the LOD score (logarithm of the odds). A LOD score of >3 is considered significant evidence for linkage, while a LOD score of <-2 excludes linkage. The LOD score is calculated by comparing the likelihood of the observed data under the assumption of linkage to the likelihood of the data under the assumption of independent assortment. The LOD score provides a measure of the strength of evidence for linkage between two genes and is widely used in genetic research.

Operant Conditioning: Reinforcement, Punishment, and More

Operant conditioning, also known as instrumental learning, is a theory of learning developed by B.F. Skinner. It suggests that people learn by interacting with their environment. Reinforcement and punishment are key concepts in operant conditioning. A reinforcer is a stimulus of event that increases the likelihood of a behavior being repeated. Reinforcement can be positive of negative. Positive reinforcement occurs when a behavior is strengthened by adding a rewarding stimulus, while negative reinforcement occurs when a behavior is strengthened by removing an unpleasant stimulus. A punisher is a stimulus that decreases the likelihood of a behavior being repeated. Positive punishment occurs when a behavior is reduced in frequency by adding an unpleasant stimulus, while negative punishment occurs when a behavior is reduced in frequency by removing a pleasant stimulus.

Primary reinforcers are instinctual desires such as food, water, social approval, and sex. Secondary reinforcers, also known as conditioned reinforcers, are not innately appreciated and people have to learn to like them through classical conditioning of other methods. Secondary reinforcers include things such as money. Different patterns of reinforcement have different influences on the response. There are five main reinforcement schedules: fixed interval, variable interval, fixed ratio, variable ratio, and random. Variable ratio schedules are most resistant to extinction.

Shaping and chaining are techniques used when an exact behavior cannot be performed and so cannot be rewarded. Shaping involves rewarding successive, increasingly accurate approximations to the behavior, while chaining involves breaking a complex task into smaller, more manageable sections. Escape conditioning refers to a situation whereby an aversive situation is removed after a response. It is a form of negative reinforcement. Habituation refers to the phenomenon whereby there is a decrease in response to a stimulus over time. Covert sensitization is a technique used whereby someone learns to use mental imagery to associate a behavior with a negative consequence.

Duloxetine is also licensed for the treatment of generalised anxiety disorder.

Antidepressants (Licensed Indications)

The following table outlines the specific licensed indications for antidepressants in adults, as per the Maudsley Guidelines and the British National Formulary. It is important to note that all antidepressants are indicated for depression.

– Nocturnal enuresis in children: Amitriptyline, Imipramine, Nortriptyline
– Phobic and obsessional states: Clomipramine
– Adjunctive treatment of cataplexy associated with narcolepsy: Clomipramine
– Panic disorder and agoraphobia: Citalopram, Escitalopram, Sertraline, Paroxetine, Venlafaxine
– Social anxiety/phobia: Escitalopram, Paroxetine, Sertraline, Moclobemide, Venlafaxine
– Generalised anxiety disorder: Escitalopram, Paroxetine, Duloxetine, Venlafaxine
– OCD: Escitalopram, Fluoxetine, Fluvoxamine, Paroxetine, Sertraline, Clomipramine
– Bulimia nervosa: Fluoxetine
– PTSD: Paroxetine, Sertraline

Medication Types:

Atomoxetine (Strattera) is a medication used to treat ADHD by inhibiting the reuptake of noradrenaline. It has a similar structure to some antidepressants.

Acamprosate is a medication that acts as an antagonist at NMDA receptors and is the only medication licensed for the relief of cravings in alcohol dependence.

Alprazolam is a benzodiazepine medication.

Amisulpride is an atypical (second generation) antipsychotic medication that works as a serotonin and dopamine antagonist.

Aripiprazole is an atypical antipsychotic medication that acts as a partial agonist at dopamine receptors.

Clozapine is an atypical antipsychotic drug that acts as an antagonist at various receptors, including dopamine, histamine, serotonin, adrenergic, and cholinergic receptors. It is mainly metabolized by CYP1A2, and its plasma levels can be affected by inducers and inhibitors of this enzyme. Clozapine is associated with several side effects, including drowsiness, constipation, weight gain, and hypersalivation. Hypersalivation is a paradoxical side effect, and its mechanism is not fully understood, but it may involve clozapine agonist activity at the muscarinic M4 receptor and antagonist activity at the alpha-2 adrenoceptor. Clozapine is also associated with several potentially dangerous adverse events, including agranulocytosis, myocarditis, seizures, severe orthostatic hypotension, increased mortality in elderly patients with dementia-related psychosis, colitis, pancreatitis, thrombocytopenia, thromboembolism, and insulin resistance and diabetes mellitus. The BNF advises caution in using clozapine in patients with prostatic hypertrophy, susceptibility to angle-closure glaucoma, and adults over 60 years. Valproate should be considered when using high doses of clozapine, plasma levels > 0.5 mg/l, of when the patient experiences seizures. Myocarditis is a rare but potentially fatal adverse event associated with clozapine use, and its diagnosis is based on biomarkers and clinical features. The mortality rate of clozapine-induced myocarditis is high, and subsequent use of clozapine in such cases leads to recurrence of myocarditis in most cases.

Mirtazapine and Mianserin are significant NaSSA’s (Noradrenergic and specific serotonergic antidepressants) that function by blocking adrenergic and serotonergic receptors. In contrast to the majority of antidepressants, they do not impact the reuptake of serotonin.

Mechanisms of Action of Different Drugs

Understanding the mechanisms of action of different drugs is crucial for medical professionals. It is a common topic in exams and can earn easy marks if studied well. This article provides a list of drugs and their mechanisms of action in different categories such as antidepressants, anti dementia drugs, mood stabilizers, anxiolytic/hypnotic drugs, antipsychotics, drugs of abuse, and other drugs. For example, mirtazapine is a noradrenaline and serotonin specific antidepressant that works as a 5HT2 antagonist, 5HT3 antagonist, H1 antagonist, alpha 1 and alpha 2 antagonist, and moderate muscarinic antagonist. Similarly, donepezil is a reversible acetylcholinesterase inhibitor used as an anti dementia drug, while valproate is a GABA agonist and NMDA antagonist used as a mood stabilizer. The article also explains the mechanisms of action of drugs such as ketamine, phencyclidine, buprenorphine, naloxone, atomoxetine, varenicline, disulfiram, acamprosate, and sildenafil.

While ventricular enlargement is often observed in individuals with schizophrenia, it is not a definitive indicator of the condition as it can also be present in other disorders.

Schizophrenia is a pathology that is characterized by a number of structural and functional brain alterations. Structural alterations include enlargement of the ventricles, reductions in total brain and gray matter volume, and regional reductions in the amygdala, parahippocampal gyrus, and temporal lobes. Antipsychotic treatment may be associated with gray matter loss over time, and even drug-naïve patients show volume reductions. Cerebral asymmetry is also reduced in affected individuals and healthy relatives. Functional alterations include diminished activation of frontal regions during cognitive tasks and increased activation of temporal regions during hallucinations. These findings suggest that schizophrenia is associated with both macroscopic and functional changes in the brain.

Courtesy stigma refers to the stigma that friends and family members of a person with a mental illness may experience due to their association with the affected individual. This can lead to secrecy about the diagnosis. Enacted stigma is the actual experience of discrimination, while felt stigma is the fear of discrimination that can prevent people from seeking help. Public stigma is the negative attitudes and reactions of the general population towards those with mental illness. Self-stigma is the internalized prejudice and reduced sense of self-worth that individuals with mental illness may experience. These terms were first introduced by Goffman in 1963.

Attachment (Ainsworth)

Psychologist Mary Ainsworth developed the ‘Strange Situation procedure’ to study and categorize attachment in children aged 12 to 18 months. The procedure involves seven steps, including two separations and two reunions, and takes place in one room. The child’s attachment is classified into one of three styles: secure, anxious-resistant, and anxious-avoidant. A fourth category, disorganized, is sometimes observed. Ainsworth suggested that the child’s attachment style is determined by the primary caregiver’s behavior.

Mary Main later developed the Adult Attachment Interview and identified four categories of attachment in adults that correspond to those observed in the strange situation. The distribution of adult attachment styles correlates with those of the strange situation, with 70% of children and adults having secure attachment. Attachment styles also seem to be passed on to subsequent generations.

Pharmacological Treatments for Alcohol Dependence

Acamprosate, when used in conjunction with counselling, has been found to be effective in helping alcohol-dependent patients with strong cravings maintain abstinence. Bupropion hydrochloride, which is primarily used as an antidepressant, has also been shown to be effective in maintaining smoking cessation. Disulfiram, on the other hand, causes an unpleasant systemic reaction when alcohol is consumed due to the buildup of acetaldehyde. Nalmefene has recently been licensed for the reduction of alcohol consumption in alcohol-dependent patients with a high drinking risk level who do not have physical withdrawal symptoms and do not require immediate detoxification. Finally, naltrexone, an opioid-receptor antagonist, may be used in the treatment of alcohol dependence after successful withdrawal.

Drug Interactions: Understanding the Different Types

Drug interactions can occur in different ways, and it is important to understand the different types to avoid potential harm. Pharmacokinetic drug interactions happen when one drug affects the metabolism, absorption, of excretion of another drug. This can be due to enzyme induction of inhibition, changes in gastrointestinal tract motility and pH, chelation, competition for renal tubular transport, of changes in protein binding. On the other hand, pharmacodynamic drug interactions occur when one drug directly alters the effect of another drug. This can happen through synergism, antagonism, of interaction at receptors, such as allosteric modulation. It is important to note that pharmacodynamic drug interactions do not involve any absorption, distribution, metabolism, of excretion processes directly. By understanding the different types of drug interactions, healthcare professionals can better manage patients’ medications and prevent potential adverse effects.

Perseveration: The Clinical Symptoms in Chronic Schizophrenia and Organic Dementia

Perseveration is a common behavior observed in patients with organic brain involvement. It is characterized by the conscious continuation of an act of an idea. This behavior is frequently seen in patients with delirium, epilepsy, dementia, schizophrenia, and normal individuals under extreme fatigue of drug-induced states.

In chronic schizophrenia and organic dementia, perseveration is a prominent symptom. Patients with these conditions tend to repeat the same words, phrases, of actions over and over again, even when it is no longer appropriate of relevant to the situation. This behavior can be frustrating for caregivers and family members, and it can also interfere with the patient’s ability to communicate effectively.

In schizophrenia, perseveration is often associated with disorganized thinking and speech. Patients may jump from one topic to another without any logical connection, and they may repeat the same words of phrases in an attempt to express their thoughts. In organic dementia, perseveration is a sign of cognitive decline and memory impairment. Patients may repeat the same stories of questions, forgetting that they have already asked of answered them.

Overall, perseveration is a common symptom in patients with organic brain involvement, and it can have a significant impact on their daily functioning and quality of life. Understanding this behavior is essential for effective management and treatment of these conditions.

Models of Doctor-Patient Relationship

There are four distinct models of doctor-patient relationship that have been identified. The first is the paternalistic of autocratic model, which assumes that the doctor knows best and makes all decisions regarding treatment. The patient is expected to simply comply with the doctor’s orders. The second model is the informative model, where the doctor provides information to the patient and leaves the decision-making process entirely up to them. The third model is the interpretive model, where the doctor takes the time to understand the patient’s circumstances and helps them make a decision based on their unique situation. This model involves shared decision-making and active participation from the patient. Finally, the deliberative model involves the doctor acting as a friend to the patient and attempting to steer them in a particular course of action that they believe is in the patient’s best interest. However, ultimately, the choice is left up to the patient. Understanding these different models can help doctors and patients work together more effectively to achieve the best possible outcomes.

Autonomy is the ability of an individual to make their own decisions, which is considered a protective factor for mental health disorders. Risk factors for mental disorders include medical illness, communication deviance, elder abuse, and caring for dementia patients. The World Health Organization (WHO) emphasizes the importance of targeting determinants that have a causal influence on the onset of mental disorders for prevention. Risk factors increase the probability, severity, and duration of major health problems, while protective factors improve people’s resistance to these risk factors and disorders. Protective factors are defined as factors that modify, ameliorate, of alter a person’s response to environmental hazards that predispose to maladaptive outcomes. Individual protective factors are often associated with positive mental health, such as self-esteem, emotional resilience, positive thinking, problem-solving and social skills, stress management skills, and feelings of mastery.

ADHD medications can be classified into stimulant and non-stimulant drugs. The therapeutic effects of these drugs are believed to be mediated through the action of noradrenaline in the prefrontal cortex. Common side effects of these drugs include decreased appetite, insomnia, nervousness, headache, and nausea. Stimulant drugs like dexamphetamine, methylphenidate, and lisdexamfetamine inhibit the reuptake of dopamine and noradrenaline. Non-stimulant drugs like atomoxetine, guanfacine, and clonidine work by increasing noradrenaline levels in the synaptic cleft through different mechanisms. The most common side effects of these drugs are decreased appetite, somnolence, headache, and abdominal pain.

Melanie Klein introduced the concepts of object relations, the depressive position, and the paranoid schizoid position. The initial stage is the paranoid schizoid position, where the infant divides their ego and perception of the mother into two opposing parts, one positive and one negative. As the child grows, they come to understand that the same person can possess both positive and negative qualities, leading to the achievement of the depressive position. Splitting is a defense mechanism that prevents the integration of positive and negative object images. Isolation is another defense mechanism that involves separating the memory of an unacceptable impulse of action from the associated emotion.

The symptoms described in the scenario are indicative of narcolepsy, specifically hypnopompic hallucinations and sleep paralysis. Narcolepsy is characterized by a set of symptoms including sleep attacks, cataplexy, sleep paralysis, and hypnagogic or hypnopompic hallucinations. Primary hypersomnia is excessive daytime sleepiness without the associated features of other sleep disorders of narcolepsy. REM sleep behavioral disorder (RBD) is characterized by complex behaviors during sleep, typically occurring during the longest periods of REM sleep and accompanied by vivid dream recall. Sleep terror disorder, also known as night terror, occurs during partial arousal from delta sleep and is typically amnestic. In contrast, the patient in the scenario was able to recall the episode of sleep paralysis. Schizophrenia cannot be diagnosed based on the symptoms described, as the criteria for hallucinations and an additional symptom from criterion A must be present for a significant portion of the time, and the symptoms can be attributed to narcolepsy.

The percentage of women who experience specific phobia at some point in their lives is 13%. The percentage of people who experience obsessive compulsive disorder within a year is 2.1%. The percentage of women who experience agoraphobia without panic disorder within a year is 3.8%. The percentage of men who experience specific phobia at some point in their lives is 4%. The percentage of people in the US National Comorbidity study who experience social phobia within a year is 7.4%. All of these statistics are based on the diagnostic criteria outlined in DSM-III R.

Antidepressants with Active Metabolites

Many antidepressants have active metabolites that can affect the body’s response to the medication. For example, amitriptyline has nortriptyline as an active metabolite, while clomipramine has desmethylclomipramine. Other antidepressants with active metabolites include dosulepin, doxepin, imipramine, lofepramine, fluoxetine, mirtazapine, trazodone, and venlafaxine.

These active metabolites can have different effects on the body compared to the original medication. For example, nortriptyline is a more potent inhibitor of serotonin and norepinephrine reuptake than amitriptyline. Similarly, desipramine, the active metabolite of imipramine and lofepramine, has a longer half-life and is less sedating than the original medication.

It is important for healthcare providers to be aware of the active metabolites of antidepressants when prescribing medication and monitoring patients for side effects and efficacy.

It is important to note that Carl Schneider should not be mistaken for Kurt Schneider. While Carl Schneider was a psychiatrist who had ties to the Nazi party and played a significant role in the Action T4 Euthanasia program, Kurt Schneider was a different individual altogether.

First Rank Symptoms: Their Significance in Identifying Schizophrenia

First rank symptoms were introduced by Kurt Schneider in 1938 as a practical tool for non-psychiatrists to identify schizophrenia. While they are highly suggestive of schizophrenia, they are not pathognomonic and can also be seen in affective and personality disorders. Additionally, there is no evidence to support their prognostic significance.

A systematic review in 2015 found that first rank symptoms differentiated schizophrenia from nonpsychotic mental health disorders with a sensitivity of 61.8% and a specificity of 94.1%. They also differentiated schizophrenia from other types of psychosis with a sensitivity of 58% and a specificity of 74.7%.

The first rank symptoms include running commentary, thought echo, voices heard arguing, thought insertion, thought withdrawal, thought broadcast, delusional perception, somatic passivity, made affect, and made volition. While they can be helpful in identifying schizophrenia, they should not be relied upon as the sole diagnostic criteria.

Robertsonian translocations can involve chromosomes with very small p arms, which are known as acrocentric chromosomes.

Understanding Centromeres

A centromere is a crucial part of DNA that connects two sister chromatids. It plays a vital role in cell division by keeping the sister chromatids aligned and allowing the chromosomes to be lined up during metaphase. The position of the centromere divides the chromosome into two arms, the long (q) and the short (p). Chromosomes are classified based on the position of the centromere. Metacentric chromosomes have arms of roughly equal length, and they can be formed by Robertsonian translocations. Acrocentric chromosomes can also be involved in Robertsonian translocations. Monocentric chromosomes have only one centromere and form a narrow constriction, while holocentric chromosomes have the entire length of the chromosome acting as the centromere. Understanding the role and classification of centromeres is essential in comprehending the process of cell division.

Transcription is the process of converting DNA into messenger RNA (mRNA) and takes place in the nucleus of a cell. RNA is similar to DNA, but with a ribose sugar backbone instead of deoxyribose, and uracil (U) instead of thymine (T).

After transcription, the mRNA is transported out of the nucleus and undergoes translation in the cytoplasm to form a protein. Ribosomes bind to the mRNA, and transfer RNA (tRNA) reads the genetic code to create the protein.

Recombination is the process of DNA detaching from one chromosome and attaching to another, resulting in new variations of chromosomes. In eukaryotes, this typically occurs during meiosis between homologous chromosome pairs.

Mini Mental State Exam (MMSE)

The Mini Mental State Exam (MMSE) was developed in 1975 by Folstein et al. Its original purpose was to differentiate between organic and functional disorders, but it is now mainly used to detect and track the progression of cognitive impairment. The exam is scored out of 30 and is divided into seven categories: orientation to place and time, registration, attention and concentration, recall, language, visual construction, and attention to written command. Each category has a possible score, and the total score can indicate the severity of cognitive impairment. A score equal to or greater than 27 indicates normal cognition, while scores below this can indicate severe, moderate, of mild cognitive impairment. The MMSE is a useful tool for detecting and tracking cognitive impairment.

While there are situations where covert administration of medication may be necessary, it is important to approach this practice with caution due to its controversial nature. In cases where covert medication is deemed necessary to improve a patient’s mental health, it is recommended to convene a ‘best interests meeting’ involving the multidisciplinary team and family. The patient’s capacity should be taken into account, regardless of whether they are detained of not. While the views of the patient’s next of kin should be considered, they should not be the sole determining factor.

The Addenbrooke’s Cognitive Exam: A Brief Screening Tool for Dementia

The Addenbrooke’s cognitive examination (ACE) is a cognitive screening tool developed to detect dementia and differentiate Alzheimer’s dementia from frontotemporal dementia. It was created to address the limitations of the MMSE, which lacked sensitivity for frontal-executive dysfunction and visuospatial defects. The ACE is a brief test that takes 15-20 minutes to administer and is divided into five domains: attention and orientation, memory, verbal fluency, language, and visuospatial abilities. The total score is based on a maximum score of 100, with higher scores indicating better cognitive functioning.

The ACE has been shown to be a valid tool for detecting dementia, with two cut-off points often used depending on the required sensitivity and specificity. A score of less than 88 has 100% sensitivity for detecting dementia, while a score of less than 82 has 93% sensitivity and 100% specificity. It has also been useful in differentiating dementia from pseudo dementia and detecting cognitive impairment in atypical Parkinson syndromes. However, while the test has shown 100% sensitivity and specificity in studies, its performance may vary in clinical practice.

Extrapyramidal side-effects (EPSE’s) are a group of side effects that affect voluntary motor control, commonly seen in patients taking antipsychotic drugs. EPSE’s include dystonias, parkinsonism, akathisia, and tardive dyskinesia. They can be frightening and uncomfortable, leading to problems with non-compliance and can even be life-threatening in the case of laryngeal dystonia. EPSE’s are thought to be due to antagonism of dopaminergic D2 receptors in the basal ganglia. Symptoms generally occur within the first few days of treatment, with dystonias appearing quickly, within a few hours of administration of the first dose. Newer antipsychotics tend to produce less EPSE’s, with clozapine carrying the lowest risk and haloperidol carrying the highest risk. Akathisia is the most resistant EPSE to treat. EPSE’s can also occur when antipsychotics are discontinued (withdrawal dystonia).